Effect of 3 Months of Antimicrobial Treatment With Clarithromycin in Acute Non–Q-Wave Coronary Syndrome-Reference-Cited by-同舟云学术

Effect of 3 Months of Antimicrobial Treatment With Clarithromycin in Acute Non–Q-Wave Coronary Syndrome

Published:2002-04-02 Issue:13 Volume:105 Page:1555-1560
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Sinisalo Juha¹,Mattila Kimmo¹,Valtonen Ville¹,Anttonen Olli¹,Juvonen Jukka¹,Melin John¹,Vuorinen-Markkola Helena¹,Nieminen Markku S.¹

Affiliation:

1. From Helsinki University Central Hospital, Department of Medicine, Division of Cardiology (J.S., H.V.-M., M.S.N.), and Infectious Diseases (K.M., V.V.), Helsinki; Lahti Central Hospital (O.A.), Lahti; Kajaani Central Hospital (J.J.), Kajaani; and Jyväskylä Central Hospital (J.M.), Jyväskylä, Finland.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference21 articles.

1. Acute coronary syndromes: biology

2. Role of Infection as a Risk Factor for Atherosclerosis, Myocardial Infarction, and Stroke

3. SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTION

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No dose-response relationship of clarithromycin utilization on cardiovascular outcomes in patients with stable coronary heart disease: Analysis of Taiwan’s national health insurance claims data;Frontiers in Cardiovascular Medicine;2022-10-26

2. A nationwide cohort study suggests clarithromycin-based therapy for Helicobacter pylori eradication is safe in patients with stable coronary heart disease and subsequent peptic ulcer disease;BMC Gastroenterology;2022-09-12

3. The evidence for a role of bacteria and viruses in cardiovascular disease;Scripta Medica;2022

4. Antibiotics for secondary prevention of coronary heart disease;Cochrane Database of Systematic Reviews;2021-02-23

5. Clarithromycin use and the risk of mortality and cardiovascular events: A systematic review and meta-analysis;PLOS ONE;2019-12-27